196 related articles for article (PubMed ID: 9218881)
1. Would any acute treatment for migraine demonstrate recurrence?
Dahlöf C
Cephalalgia; 1997 Jun; 17 Suppl 17():17-9; discussion 19-20. PubMed ID: 9218881
[No Abstract] [Full Text] [Related]
2. Zolmitriptan. Introduction.
Mathew N
Cephalalgia; 1997 Oct; 17 Suppl 18():1-3. PubMed ID: 9399011
[No Abstract] [Full Text] [Related]
3. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
Bartleson JD
Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
[No Abstract] [Full Text] [Related]
4. Newer intranasal migraine medications.
Logemann CD; Rankin LM
Am Fam Physician; 2000 Jan; 61(1):180-6. PubMed ID: 10643958
[TBL] [Abstract][Full Text] [Related]
5. [Choice of triptan in migraine].
Salvesen R
Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3410-1. PubMed ID: 11826788
[No Abstract] [Full Text] [Related]
6. [Improved pharmacokinetics. Fast tryptan with sustained response].
MMW Fortschr Med; 2003 May; 145 Suppl 2():106-7. PubMed ID: 14579498
[No Abstract] [Full Text] [Related]
7. Migraine revolution and sumatriptan.
Palmer JB; Salonen R
Lancet; 2000 Jun; 355(9222):2250-1. PubMed ID: 10881915
[No Abstract] [Full Text] [Related]
8. [Zolmitriptan].
Monseu G; Sternon J
Rev Med Brux; 1998 Dec; 19(6):495-9. PubMed ID: 9916496
[TBL] [Abstract][Full Text] [Related]
9. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Deleu D; Hanssens Y
Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
[TBL] [Abstract][Full Text] [Related]
10. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
Mathew NT; Kailasam J; Gentry P; Chernyshev O
Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of new therapeutic deliveries in migraine.
Dahlöf C
Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
[TBL] [Abstract][Full Text] [Related]
12. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
Lines C; Visser WH
Int J Clin Pract; 2004 Mar; 58(3):322; author reply 322-3. PubMed ID: 15117106
[No Abstract] [Full Text] [Related]
13. The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers.
Seaber E; On N; Phillips S; Churchus R; Posner J; Rolan P
Br J Clin Pharmacol; 1996 Feb; 41(2):141-7. PubMed ID: 8838441
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design.
Geraud G; Olesen J; Pfaffenrath V; Tfelt-Hansen P; Zupping R; Diener HC; Sweet R
Cephalalgia; 2000 Feb; 20(1):30-8. PubMed ID: 10817444
[TBL] [Abstract][Full Text] [Related]
15. Sumatriptan fast-disintegrating/rapid-release tablets: viewpoints.
Carpay HA; Dowson AJ
Drugs; 2006; 66(6):891-2. PubMed ID: 16706566
[No Abstract] [Full Text] [Related]
16. Zolmitriptan.
Can Fam Physician; 1999 Jun; 45():1491-4, 1497-501. PubMed ID: 10386213
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
Welch KM
Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
[No Abstract] [Full Text] [Related]
18. The scientific basis of medication choice in symptomatic migraine treatment.
Goadsby PJ
Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S20-6. PubMed ID: 10563229
[TBL] [Abstract][Full Text] [Related]
19. Building on the sumatriptan experience: the development of naratriptan.
Connor HE
Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
[No Abstract] [Full Text] [Related]
20. How effective are triptans in the treatment of episodic and chronic cluster headache.
Millson DS
Ital J Neurol Sci; 1999 Apr; 20(2 Suppl):S69-71. PubMed ID: 10662946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
